These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20101535)

  • 1. Partial mechanical long-term support with the CircuLite Synergy pump as bridge-to-transplant in congestive heart failure.
    Klotz S; Meyns B; Simon A; Wittwer T; Rahmanian P; Schlensak C; Tjan TT; Scheld HH; Burkhoff D
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S173-8. PubMed ID: 20101535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients.
    Meyns BP; Simon A; Klotz S; Wittwer T; Schlensak C; Rega F; Burkhoff D
    Eur J Cardiothorac Surg; 2011 May; 39(5):693-8. PubMed ID: 20934882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump.
    Meyns B; Klotz S; Simon A; Droogne W; Rega F; Griffith B; Dowling R; Zucker MJ; Burkhoff D
    J Am Coll Cardiol; 2009 Jun; 54(1):79-86. PubMed ID: 19555845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CircuLite Synergy ventricular assist device: a new approach to end-stage congestive heart failure].
    Barbone A; Pini D; Ornaghi D; Visigalli MM; Ardino L; Bragato R; Curzi M; Cioccarelli SA; Di Diodoro L; Basciu A; Cappai A; Settepani F; Citterio E; Cappelleri A; Calcagnino M; Mangiavacchi M; Tarelli G; Lettino M; Vitali E
    G Ital Cardiol (Rome); 2014 Feb; 15(2):116-22. PubMed ID: 24625851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term support of 9 patients with the DeBakey VAD for more than 200 days.
    Wilhelm MJ; Hammel D; Schmid C; Rhode A; Kaan T; Rothenburger M; Stypmann J; Schäfers M; Schmidt C; Baba HA; Scheld HH
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1122-9. PubMed ID: 16214529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support.
    Branch KR; Dembitsky WP; Peterson KL; Adamson R; Gordon JB; Smith SC; Jaski BE
    J Heart Lung Transplant; 1994; 13(4):641-50; discussion 651. PubMed ID: 7947881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent mechanical circulatory support in patients of advanced age.
    Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient.
    Russo MJ; Jeevanandam V; Stepney J; Merlo A; Johnson EM; Malyala R; Raman J
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):951-5. PubMed ID: 22520721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
    Morley D; Litwak K; Ferber P; Spence P; Dowling R; Meyns B; Griffith B; Burkhoff D
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):21-8. PubMed ID: 17198776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.